Griseofulvin is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is Griseofulvin.
Product ID | 0713-0850_ec12736b-25fb-dea8-e053-2995a90a2d02 |
NDC | 0713-0850 |
Product Type | Human Prescription Drug |
Proprietary Name | Griseofulvin |
Generic Name | Griseofulvin |
Dosage Form | Suspension |
Route of Administration | ORAL |
Marketing Start Date | 2022-11-01 |
Marketing Category | ANDA / |
Application Number | ANDA065438 |
Labeler Name | Cosette Pharmaceuticals, Inc. |
Substance Name | GRISEOFULVIN |
Active Ingredient Strength | 125 mg/5mL |
Pharm Classes | Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-11-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0472-0013 | Griseofulvin | Griseofulvin |
0713-0850 | Griseofulvin | Griseofulvin |
0781-5514 | Griseofulvin | Griseofulvin |
0781-5515 | Griseofulvin | Griseofulvin |
42794-012 | Griseofulvin | Griseofulvin |
42794-013 | Griseofulvin | Griseofulvin |
42794-014 | Griseofulvin | Griseofulvin |
62135-968 | Griseofulvin | Griseofulvin (microsize) |
64980-184 | Griseofulvin | Griseofulvin |
64980-185 | Griseofulvin | Griseofulvin |
64980-186 | Griseofulvin | Griseofulvin |
68682-519 | Griseofulvin | Griseofulvin |
68682-520 | Griseofulvin | Griseofulvin |
0884-0763 | Gris-PEG | griseofulvin |
0884-0773 | Gris-PEG | griseofulvin |
53808-0261 | Gris-PEG | GRISEOFULVIN |
62135-496 | Griseofulvin MICROSIZE | griseofulvin |
62135-494 | Ultramicrosize Griseofulvin | Griseofulvin |
62135-495 | Ultramicrosize Griseofulvin | Griseofulvin |